Subscribe
U.S. Army Lt. Col. Nathan McWhorter, chief of Nuclear Medicine, consults with patient, Harold G. Overstreet, retired Sgt. Maj. of the Marine Corps at Brooke Army Medical Center, Fort Sam Houston, Texas, Sept. 27, 2022. Overstreet is undergoing a new treatment for prostate cancer patients which is combined with a specific type of positron emission tomography (PET) imaging agent for prostate cancer. The PET imaging allows the doctor to see where the cancer is located as well as the extent of metastasis. The new FDA-approved prostate-specific membrane antigen (PSMA) PET imaging scan significantly improves prostate cancer detection and treatment. (U.S. Army photo by Jason W. Edwards)
| Date Taken: | 09.27.2022 |
| Date Posted: | 10.24.2022 10:31 |
| Photo ID: | 7476941 |
| VIRIN: | 220927-A-HZ730-3652 |
| Resolution: | 6770x4518 |
| Size: | 5.46 MB |
| Location: | JOINT BASE SAN ANTONIO, TEXAS, US |
| Web Views: | 128 |
| Downloads: | 21 |
This work, BAMC provides new prostate cancer treatment, by Jason W. Edwards, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
